KRAS and neoplasm: This list is enriched for tumor neoantigens presented on HLA-C alleles such as KRAS(G12V) (GAVGVGKSA)/C*0304, KRAS(G12C) (GACGVGKSA)/C*0304, KRAS(G12D) (GADGVGKSA)/C*0802 and EGFR(T790M) (LTSTVQLIM)/C*0701 (refs. 15,29–32), highlighting the sensitivity of ESCAPE-seq to identify HLA-C-presented tumor neoantigens that are missed by computational prediction (Fig. 4g).